GTLB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now: trend is still bearish (SMA_200 > SMA_20 > SMA_5 + MACD histogram negative and worsening), and price is slipping under near-term support (~32.49).", "With no Intellectia buy signals today and rising competitive/monetization uncertainty, the risk/reward is unfavorable for an impatient entry.", "If you must act immediately, the higher-probability move is to avoid/new-sell now and reassess only after a clear reversal (e.g., reclaiming ~35.26 pivot and stabilizing momentum)."]
["Trend: Bearish alignment (SMA_200 > SMA_20 > SMA_5) indicates sustained downtrend and weak intermediate momentum.", "Momentum: MACD histogram -0.152 below zero and expanding negatively = downside momentum is strengthening, not fading yet.", "RSI(6): 27.09 = oversold/washed-out conditions, which can produce bounces, but oversold in a downtrend often isn\u2019t a reliable buy signal without confirmation.", "Key levels: Support S1 32.49 (current ~32.54; post-market ~32.16 is below/at risk), next support S2 ~30.78. Resistance/pivot ~35.26, then R1 ~38.04.", "Pattern-based odds: Similar-pattern model suggests a modest bounce bias (70% chance) but with small expected move next day (+1.38%); this is not strong enough to override the broader downtrend."]
["AI/dev-tooling tailwinds: Narrative that GenAI increases software creation and can expand budgets for developer platforms (supports longer-term demand).", "Product relevance: \u201cVibe-coding\u201d and enterprise security/compliance needs can keep a trusted DevSecOps platform sticky.", "Revenue growth remains solid: Latest reported quarter still delivered +24.64% YoY revenue growth (supports fundamental durability)."]
with next support ~30.78, increasing near-term downside risk.", "Competitive pressure: Analysts explicitly cite Microsoft GitHub improving regulatory/AI capabilities, eroding GitLab differentiation.", "Go-to-market execution concerns: Uneven sales execution and incentive changes may take time to translate into productivity improvement.", "Monetization/model risk: Shift to hybrid seat-plus-usage pricing introduces near-term uncertainty and potential customer pushback.", "Profitability setback: Net loss widened materially YoY in the latest quarter and gross margin dipped."]
["Latest quarter: 2026/Q3.", "Revenue: 244.353M, up +24.64% YoY (growth still healthy but prior commentary suggests deceleration risk).", "Profitability: Net income -8.276M, down -127.99% YoY (loss widened significantly).", "EPS: -0.05, down -127.78% YoY (negative operating leverage in the quarter).", "Gross margin: 86.81%, down -2.14% YoY (still high, but trending slightly worse)."]
["Recent trend: Mostly price target cuts and caution; one notable downgrade (Cantor to Neutral from Overweight, PT cut to $40 from $60).", "Supportive voices remain: RBC maintains Outperform (PT cut to $48), Piper keeps Overweight (PT cut to $55), BTIG initiated Buy (PT $52).", "More balanced/neutral stances: KeyBanc downgraded to Sector Weight; JPMorgan remains Neutral; Truist Hold with lower PT.", "Wall Street pros: Long-term GenAI/dev tooling exposure, durable revenue growth, and product roadmap potential (e.g., AI agents) could re-rate the stock if execution improves.", "Wall Street cons: Rising GitHub competition, GTM inconsistency, and pricing/usage-model transition risk are the dominant near-term headwinds."]
